Professional Education
Module 6: Controlled Substance Utilization Review and Evaluation System (CURES) (Innovations and Smart Approaches in Safe Prescribing)
This program reviews the CURES electronic database for Schedule II, III, IV, V controlled substance prescriptions dispensed in California, including time requirements involved when dispensing information needs to be reported (a controlled substance is released to the patient or patient's representative). This module will examine how non-DEA licensed physicians and surgeon practitioners can access CURES data. This module consists of four audio-filled videos. To successfully complete this course, you need to achieve a passing score of 80 percent in the post-test questions.
Search
Mar 04, 2024
Patient Safety Impact Story: Documentation Can Prevent Litigation
Our experts partnered with a general surgery practice to dramatically improve its after-hours call documentation rate.
From
The Doctor’s Advocate
Expert Insights and Resources for Changing Healthcare
The Insurance Marketing and Communications Association (IMCA) recognized The Doctors Company for its exceptional efforts to educate and support healthcare professionals as they navigate the rapidly changing healthcare industry, especially as they adapt to evolving technologies.
Mar 07, 2025
The Doctors Company and TDC Group Win Awards for Automated Underwriting Platform and Digital Healthcare Content
The Doctors Company and TDC Group win several awards, our COO is reappointed to the California Insurance Guarantee Association Board of Governors, and we release a new malpractice closed claims study examining incidental findings.
From
The Doctor’s Advocate
November 14, 2025, Digital Health Association
The Doctors Company Wins Fall 2025 Digital Health Award
The Doctors Company is honored to win a Fall 2025 Digital Health Award for our report "The Future of Healthcare Survey: Facing Diminished Trust, Doctors Question Their Calling."
May 21, 2025, Chicago Medicine
Professional Liability Consolidation Intensifies as Healthcare Costs Rise
Richard E. Anderson, MD, FACP, Chairman and CEO of The Doctors Company and TDC Group, discusses The Doctors Company's recent announcement to acquire ProAssurance.
May 09, 2026, Risk & Insurance
The 5th Insurance Investment Executives’ Annual Meeting: Focused Education
T.C. Wilson, Chief Investment Officer for The Doctors Company, shares his perspective on the value of collaboration and strategic dialogue as insurers navigate today’s evolving economic landscape.
February 26, 2026, MDLinx
AI and Malpractice Risk: Are You Exposed?
Deepika Srivastava, Chief Operating Officer for The Doctors Company, discusses how the rapid pace of AI development in medicine is creating gaps in regulation and understanding.
February 13, 2026, Claims Journal
Review Shows Diagnosis and Treatment Issues Drive Claims in Cardiology
Diagnosis‑related failures and medical treatment issues continue to drive the majority of cardiology malpractice claims, according to a new analysis.
June 25, 2025, Business Insurance
Doctors Aren’t Talking Up Their Career: Survey
According to a recent study conducted by The Doctors Company, only 12 percent of doctors are likely to recommend that people join their profession.
